Physician Profile

Saint Luke’s Care Member

Physician Profile

Adnan K Chhatriwalla, MD

Cardiology, Interventional Cardiology


Medical School
Case Western Reserve School of Medicine, Cleveland, OH
Internal Medicine, University of Virginia Health System, Charlottesville, VA
Cardiovascular Disease, Cleveland Clinic, Cleveland, OH
Interventional Cardiology, Cleveland Clinic, Cleveland, OH

Board Certifications

  • American Board of Internal Medicine - Subspecialty in Cardiovascular Disease
  • American Board of Internal Medicine - Subspecialty in Interventional Cardiology

Academic Titles

  • Assistant Professor, University of Missouri–Kansas City School of Medicine
  • Physician Mentor - University of Kansas

Clinical Interests

  • coronary artery disease
  • interventional cardiology percutaneous coronary intervention
  • transcatheter aortic valve replacement


Dr. Chhatriwalla is an interventional cardiologist and Clinical Scholar and Saint Luke’s Mid America Heart Institute, and an Assistant Professor of Medicine at the University of Missouri-Kansas City.  He specializes in coronary, peripheral and structural interventions, including transcatheter aortic valve replacement (TAVR).  Dr. Chhatriwalla received his medical degree from Case Western Reserve University School of Medicine in Cleveland, OH.  He completed an Internal Medicine residency at the University of Virginia in Charlottesville, VA and Cardiology and Interventional Cardiology fellowships at the Cleveland Clinic in Cleveland, OH.


Accepted Insurances

  • Aetna Choice POS II
  • Aetna Choice POS II Aexcel Local
  • Aetna Choice POS II Local
  • Aetna Elect Choice
  • Aetna Federal Employees Health Benefit Plan
  • Aetna HMO
  • Aetna HMO Local
  • Aetna Mail Handlers Benefit Plan
  • Aetna Managed Choice
  • Aetna MDOT & Missouri State Highway Patrol
  • Aetna Medicare
  • Aetna Missouri Preferred
  • Aetna MU myChoice Health Program
  • Aetna Open Choice PPO
  • Aetna Select
  • Aetna Select Local
  • Aetna Signature Administrators (ASA)
  • Aetna Workers Comp
  • BCBS of Kansas (call provider)
  • BCBS of Kansas City (PPO)
  • BCBS of Kansas City Freedom Network
  • BCBS of Kansas City Freedom Network Select
  • BCBS of Kansas City Preferred Care
  • BCBS of Kansas City Preferred Care Blue
  • BCBS of Kansas City Traditional
  • Beech Street (PPO)
  • Century Health Solutions (PPO)
  • Cigna (HMO)
  • Cigna (Open Access)
  • Cigna (PPO)
  • Cigna HealthSpring (HMO Medicare Advantage)
  • CompResults (WC)
  • Coventry Advantra Freedom (PPO)
  • Coventry Health and Life Insurance Company
  • Coventry Health Care
  • Coventry Medicare Advantra (PPO)
  • Golden Rule
  • Great West HealthCare (POS)
  • Great West HealthCare (PPO)
  • Great West HealthCare One Health Plan
  • Great West HealthCare One Health Plan/Gen AM
  • Health Choice of Northwest Missouri (PPO)
  • Healthcare USA-MC+ (Aetna Better Health)
  • HealthLink (HMO)
  • HealthLink (PPO) through Freedom Network
  • Home State Health Plan (Missouri practices)
  • Humana (PPOx)
  • Humana Choice Care (PPO)
  • Humana Choice PPO (Medicare Advantage PPO)
  • Humana Gold Choice Medicare Advantage PFFS
  • Humana Gold Plus (HMO)
  • Humana Gold Plus HMO SNP
  • Humana SmartExpress PPO
  • Humana SmartNet PPO
  • Humana SmartSuite PPO
  • HumanaOne
  • Integrated Health Plan
  • Kansas Medicaid
  • Medicare
  • Missouri Care (Missouri practices only)
  • Missouri Medicaid
  • MultiPlan/PCHS (PPO)
  • Occupational Health Management (WC)
  • OHARA Managed Care (WC)
  • ProviDRs Care Network (formerly WPPA)
  • Pyramid Life (Medicare Advantage PPO)
  • Railroad Medicare
  • Sunflower State Health Plan (Kansas practices)
  • Triwest Veterans Affairs Patient Centered Community Care
  • United Healthcare Choice
  • United Healthcare Choice Plus
  • United Healthcare Community Plan
  • United Healthcare Definity Health Reimbursement Account
  • United Healthcare Definity Health Savings Account
  • United Healthcare Golden Rule HMO
  • United Healthcare Indemnity
  • United Healthcare Managed Indemnity
  • United Healthcare Options PPO
  • United Healthcare Select
  • United Healthcare Select Plus
  • UnitedHealthcare Evercare DH
  • UnitedHealthcare Evercare DH-POS
  • UnitedHealthcare Evercare DP
  • UnitedHealthcare Evercare RDP
  • UnitedHealthcare Medicare Choice
  • UnitedHealthcare Medicare Choice Essential
  • UnitedHealthcare Medicare Complete
  • UnitedHealthcare Medicare Complete Essential
  • UnitedHealthcare Medicare Complete Plus
  • UnitedHealthcare Medicare DH
  • UnitedHealthcare Medicare Plus Essential
  • US Department of Labor


1. Costs of transradial percutaneous coronary intervention. Amin AP, House JA, Safley DM, Chhatriwalla AK, Giersiefen H, Bremer A, Hamon M, Baklanov DV, Aluko A, Wohns D, Mathias DW, Applegate RA, Cohen DJ, Marso SP. JACC Cardiovasc Interv. 2013 Aug;6(8):827-34. doi: 10.1016/j.jcin.2013.04.014. Epub 2013 Jul 17.

2. Nuisance bleeding with prolonged dual antiplatelet therapy after acute myocardial infarction and its impact on health status. Amin AP, Bachuwar A, Reid KJ, Chhatriwalla AK, Salisbury AC, Yeh RW, Kosiborod M, Wang TY, Alexander KP, Gosch K, Cohen DJ, Spertus JA, Bach RG. J Am Coll Cardiol. 2013 May 28;61(21):2130-8. doi: 10.1016/j.jacc.2013.02.044. Epub 2013 Mar 26.

3. Pre-procedural estimate of individualized bleeding risk impacts physicians' utilization of bivalirudin during percutaneous coronary intervention. Rao SC, Chhatriwalla AK, Kennedy KF, Decker CJ, Gialde E, Spertus JA, Marso SP. J Am Coll Cardiol. 2013 May 7;61(18):1847-52. doi: 10.1016/j.jacc.2013.02.017. Epub 2013 Mar 7.

4. Association between bleeding events and in-hospital mortality after percutaneous coronary intervention. Chhatriwalla AK, Amin AP, Kennedy KF, House JA, Cohen DJ, Rao SV, Messenger JC, Marso SP; National Cardiovascular Data Registry. JAMA. 2013 Mar 13;309(10):1022-9. doi: 10.1001/jama.2013.1556. Erratum in: JAMA. 2013 Aug 14;310(6):647.

5. Use of the Kansas City Cardiomyopathy Questionnaire for monitoring health status in patients with aortic stenosis. Arnold SV, Spertus JA, Lei Y, Allen KB, Chhatriwalla AK, Leon MB, Smith CR, Reynolds MR, Webb JG, Svensson LG, Cohen DJ. Circ Heart Fail. 2013 Jan;6(1):61-7. doi: 10.1161/CIRCHEARTFAILURE.112.970053. Epub 2012 Dec 10.

6. Use of drug-eluting stents as a function of predicted benefit: clinical and economic implications of current practice. Amin AP, Spertus JA, Cohen DJ, Chhatriwalla A, Kennedy KF, Vilain K, Salisbury AC, Venkitachalam L, Lai SM, Mauri L, Normand SL, Rumsfeld JS, Messenger JC, Yeh RW. Arch Intern Med. 2012 Aug 13;172(15):1145-52. doi: 10.1001/archinternmed.2012.3093.

7. Ambulation following cardiac catheterization: the earlier the better. Khalid A, Bhatti S, Chhatriwalla AK. Anadolu Kardiyol Derg. 2012 May;12(3):231-2. doi: 10.5152/akd.2012.066. Epub 2012 Feb 24. No abstract available.

8. Transcatheter versus surgical aortic-valve replacement in high-risk patients. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ; PARTNER Trial Investigators. N Engl J Med. 2011 Jun 9;364(23):2187-98. doi: 10.1056/NEJMoa1103510. Epub 2011 Jun 5.

9. Recurrent stent fracture in the right coronary artery. Chhatriwalla AK, Unzek S, Kapadia SR. Clin Cardiol. 2010 Dec;33(12):E70-2. doi: 10.1002/clc.20739. Epub 2010 Nov 11. No abstract available. PMID: 21184548 [PubMed - indexed for MEDLINE]

10. Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial. Topol EJ, Bousser MG, Fox KA, Creager MA, Despres JP, Easton JD, Hamm CW, Montalescot G, Steg PG, Pearson TA, Cohen E, Gaudin C, Job B, Murphy JH, Bhatt DL; CRESCENDO Investigators. Lancet. 2010 Aug 14;376(9740):517-23. doi: 10.1016/S0140-6736(10)60935-X.

11. Fulminant myocarditis due to H1N1 influenza. Al-Amoodi M, Rao K, Rao S, Brewer JH, Magalski A, Chhatriwalla AK. Circ Heart Fail. 2010 May;3(3):e7-9. doi: 10.1161/CIRCHEARTFAILURE.110.938506. No abstract available. PMID: 20484193 [PubMed - indexed for MEDLINE] Free Article

12. Should dual antiplatelet therapy after drug-eluting stents be continued for more than 1 year?: Dual antiplatelet therapy after drug-eluting stents should be continued for more than one year and preferably indefinitely. Chhatriwalla AK, Bhatt DL. Circ Cardiovasc Interv. 2008 Dec;1(3):217-25. doi: 10.1161/CIRCINTERVENTIONS.108.811380. No abstract available.

13. Limitations of angiography for the assessment of renal artery stenosis and treatment implications. Cam A, Chhatriwalla AK, Kapadia SR. Catheter Cardiovasc Interv. 2010 Jan 1;75(1):38-42. doi: 10.1002/ccd.22177.

14. Drug-eluting stent fracture and acute coronary syndrome. Chhatriwalla AK, Cam A, Unzek S, Bhatt DL, Raymond RE, Lincoff AM, Whitlow PL, Ellis SG, Tuzcu EM, Kapadia SR. Cardiovasc Revasc Med. 2009 Jul-Sep;10(3):166-71. doi: 10.1016/j.carrev.2009.02.003. Review.

15. Impact of drug-eluting versus bare-metal stents on mortality in patients with anemia. Shishehbor MH, Filby SJ, Chhatriwalla AK, Christofferson RD, Jain A, Kapadia SR, Lincoff AM, Bhatt DL, Ellis SG. JACC Cardiovasc Interv. 2009 Apr;2(4):329-36. doi: 10.1016/j.jcin.2008.11.014.

16. Role of invasive evaluation with cineradiography and intracardiac echocardiography to detect mechanical prosthetic valve dysfunction. Chhatriwalla AK, Lever HM, Pettersson G, Kapadia S. J Invasive Cardiol. 2009 Apr;21(4):190-2.

17. Low levels of low-density lipoprotein cholesterol and blood pressure and progression of coronary atherosclerosis. Chhatriwalla AK, Nicholls SJ, Wang TH, Wolski K, Sipahi I, Crowe T, Schoenhagen P, Kapadia S, Tuzcu EM, Nissen SE. J Am Coll Cardiol. 2009 Mar 31;53(13):1110-5. doi: 10.1016/j.jacc.2008.09.065.

18. Measurement of left ventricular mass by contrast ventriculography. Chhatriwalla AK, Kramer CM, Peixoto AJ, Samady H. Clin Cardiol. 2008 Jul;31(7):323-7. doi: 10.1002/clc.20223.

19. Breaking with tradition: is diagnostic angiography really necessary before primary PCI? Chhatriwalla AK, Bhatt DL. J Invasive Cardiol. 2008 May;20(5):229-30. No abstract available.

20. Preliminary data on the diagnostic accuracy of rubidium-82 cardiac PET perfusion imaging for the evaluation of ischemia in a pediatric population. Chhatriwalla AK, Prieto LR, Brunken RC, Cerqueira MD, Younoszai A, Jaber WA. Pediatr Cardiol. 2008 Jul;29(4):732-8. doi: 10.1007/s00246-008-9232-1. Epub 2008 May 6.

21. Impact of statins on atherosclerotic plaque. Nicholls SJ, Chhatriwalla AK, Lundman P. Future Cardiol. 2007 Mar;3(2):157-64. doi: 10.2217/14796678.3.2.157.

22. Myocardial infarction secondary to a coronary ostial thrombus in antiphospholipid syndrome. Abu Romeh IS, Chhatriwalla AK, Atik FA, Bhatt DL, Navia JL. Ann Thorac Surg. 2007 Mar;83(3):1170-1.

23. Walk this way: early ambulation after cardiac catheterization--good for the patient and the health care system. Chhatriwalla AK, Bhatt DL. Mayo Clin Proc. 2006 Dec;81(12):1535-6. No abstract available.

24. High left ventricular mass index does not limit the utility of fractional flow reserve for the physiologic assessment of lesion severity. Chhatriwalla AK, Ragosta M, Powers ER, Sarembock IJ, Gimple LW, Fischer JJ, Barringhaus KG, Kramer CM, Samady H. J Invasive Cardiol. 2006 Nov;18(11):544-9.

25. The ASTEROID trial: coronary plaque regression with high-dose statin therapy. Chhatriwalla AK, Nicholls SJ, Nissen SE. Future Cardiol. 2006 Nov;2(6):651-4. doi: 10.2217/14796678.2.6.651.

26. An 8-month-old girl with an anomalous left coronary artery from the pulmonary artery complicated by myocardial ischemia after surgical reimplantation. Chhatriwalla AK, Younoszai A, Latson L, Jaber WA. J Nucl Cardiol. 2006 May-Jun;13(3):432-6. No abstract available.

27. You can't keep a good man (or woman) down. Chhatriwalla AK, Bhatt DL. J Invasive Cardiol. 2006 Mar;18(3):109-10. Review. No abstract available.

28. Factors Influencing 1,4-Asymmetric Induction during Indium-Promoted Coupling of Oxygen-Substituted Allylic Bromides to Aldehydes in Aqueous Solution. Paquette LA, Bennett GD, Chhatriwalla A, Isaac MB. J Org Chem. 1997 May 16;62(10):3370-3374.

29. Theophylline toxicity after dyphylline therapy. Ackerman BL, Chhatriwalla A. Am Rev Respir Dis. 1982 Apr;125(4):484. No abstract available.

On Staff At

  • Anderson County Hospital
  • Hedrick Medical Center
  • Saint Luke's Cushing Hospital
  • Saint Luke's East Hospital
  • Saint Luke's Hospital of Kansas City
  • Saint Luke's North Hospital–Barry Road
  • Saint Luke's North Hospital–Smithville
  • Saint Luke's South Hospital
  • Wright Memorial Hospital